ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,646,289 | -17.3% | 150,346 | 0.0% | 0.01% | -25.0% |
Q2 2023 | $1,990,581 | -2.7% | 150,346 | 0.0% | 0.01% | +9.1% |
Q1 2023 | $2,046,209 | -30.3% | 150,346 | 0.0% | 0.01% | -38.9% |
Q4 2022 | $2,936,257 | +2.5% | 150,346 | 0.0% | 0.02% | -5.3% |
Q3 2022 | $2,864,000 | -7.5% | 150,346 | 0.0% | 0.02% | +5.6% |
Q2 2022 | $3,097,000 | -36.0% | 150,346 | 0.0% | 0.02% | -35.7% |
Q1 2022 | $4,838,000 | -30.9% | 150,346 | 0.0% | 0.03% | -17.6% |
Q4 2021 | $7,000,000 | +72.5% | 150,346 | 0.0% | 0.03% | +88.9% |
Q3 2021 | $4,059,000 | +5.3% | 150,346 | 0.0% | 0.02% | +5.9% |
Q2 2021 | $3,856,000 | -25.0% | 150,346 | 0.0% | 0.02% | -22.7% |
Q1 2021 | $5,139,000 | +1.1% | 150,346 | 0.0% | 0.02% | +15.8% |
Q4 2020 | $5,085,000 | +23.0% | 150,346 | -10.3% | 0.02% | +11.8% |
Q3 2020 | $4,134,000 | – | 167,562 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |